Johnson & Johnson (JNJ) is a publicly traded Healthcare sector company. As of August 16, 2026, JNJ trades at $260.89 with a market cap of $627.42B and a P/E ratio of 29.88. JNJ moved -0.66% today. Year to date, JNJ is +25.80%; over the trailing twelve months it is +49.01%. Its 52-week range spans $140.68 to $274.90. Analyst consensus is strong buy with an average price target of $283.69. Rallies surfaces JNJ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest JNJ news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $260.89 |
| Market Cap | $627.42B |
| P/E Ratio | 29.88 |
| EPS | $8.73 |
| Dividend Yield | 1.34% |
| 52-Week High | $274.90 |
| 52-Week Low | $140.68 |
| Volume | 2.84M |
| Avg Volume | 0 |
| Revenue (TTM) | $97.93B |
| Net Income | $21.04B |
| Gross Margin | 67.91% |
16 analysts cover JNJ: 0 strong buy, 13 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $283.69.